Subscribe to Search results

In a memo, Mr Harris wrote regarding Abbott's complaint that the UK could have had a test in place months ago: "we have dallied to allow the preferred UK manufacturer to catch up".

Published on:

The Committee to Study HIV Transmission Through Blood and Blood Products made the following recommendation to the Department of Health and Human Services in the United States: "Where uncertainties or countervailing public health concerns preclude completely eliminating potential risks, the FDA should encourage, and where necessary require, the blood industry to implement partial solutions that have little risk of causing harm."

Published on:

The Department of Health and Social Security proposed to set up an evaluation programme for investigating the performance of screening test systems for AIDS markers.

Published on:

Dr Cash confirmed to Dr Mitchell that "the WBTS should undertake, on behalf of the SNBTS, initial evaluation studies of commercial HTLV-III antibody kits, but current pressure from commercial organisations to meet their deadlines should be resisted and priority given to SNBTS interests."

Published on:

Dr Harris wrote to Dr Whitehead stating that although screening tests were being introduced in 1985/1986, it had become apparent at a regional general meeting of the Northern Region that screening had already been undertaken by the Public Health Laboratory Service and Dr Codd in Newcastle.

Published on:

Dr Acheson wrote to Dr Abrams and told his deputy that "unresolved technical challenges facing the UK test mean that it is unlikely to be first in the field", adding "We are likely to need to evaluate a number of other tests, largely from the United States, over the succeeding months".

Published on:

A technical evaluation of Abbott Laboratories' AIDS antibody test and one other was expected to be completed by July 1985. Mr Harris expressed to the minister the Health Services Division's view that "it would not be helpful to have no other choice than Abbott since their test requires special equipment" and that "it would be preferable to have a British test evaluated as a possible candidate".

Published on:

Further dates announced for witness hearings

Published on:

A briefing from Charles Lister, Department of Health, to Lord Philip Hunt, the Parliamentary Under-Secretary of State for Health in the House of Lords, on Hepatitis C litigation key findings, noted that there were legitimate expectations that surrogate testing and anti-Hepatitis C screening should had been introduced earlier.

Published on:

Charles Lister, Department of Health, recommended to Lord Philip Hunt, the Parliamentary Under-Secretary of State for Health in the House of Lords, that the court judgment in the "A and Others v National Blood Authority" should not be appealed.

Published on:

An email from Christine Dora to Mairi Gibson and others indicated that Officials in Scotland were keen on an appeal against the court judgment in "A and Others v National Blood Authority".

Published on:

Dr Aileen Keel regarded the Department of Health's decision not to appeal in "A and Others v National Blood Authority" as "lamentable".

Published on:

In his letter to Susan Deacon MSP, Minister for Health and Community Care, Philip Hunt, the Parliamentary Under-Secretary of State for Health in the House of Lords, noted the decision of the ministers not to appeal in "A and Others v National Blood Authority", although with some reluctance.

Published on:

John Hutton told the Parliament that "as soon as technology became available to render blood products safe, it was introduced."

Published on:

A draft speech on Hepatitis C prepared by officials for the Parliament Adjournment Debate asserted that: "The technology to make blood products free from hepatitis C in sufficient quantities to treat all haemophiliacs in the UK was simply not possible prior to 1985. Once it was the NHS introduced it."

Published on:

In preparation for a meeting with the Minister of Health, Vicki King sent a draft speech on Hepatitis C for the Adjournment Debate to Jane Colman._

Published on:

Carol Grayson wrote to Baroness Andrews pointing out "the whole-blood hepatitis C cases that were won where the judge stated that testing/screening of blood donors for hepatitis C should have been introduced prior to 1991, and that the country should have acted as other European countries did and adopted testing earlier, erring on the side of caution even if there were some false positive test results".

Published on:

Richard Gutowski, in his statement to the Inquiry, recognised that the lines to take drafted for the Government relating to donor screening for Hepatitis C could have better reflected the findings of the Court in "A & others [2001] EWHC QB 446".

Published on:

A brief by Scottish Executive officials stated, in relation to the introduction of Hepatitis C screening in 1991, that this development was introduced as early as it reasonably could be in the light of the scientific knowledge and technical capabilities at that time.

Published on:

An update for the Secretary of State dated 29 March 2005 emphasised that donor screening for Hepatitis C was introduced in the UK in 1991 and the development of this test marked a major advance in microbiological technology, which could not have been implemented before this time.

Published on: